| 2024 | 2023 | 2022 | 2021 | 2020 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | -97,5 k € | +32.4% | -144,2 k € | -62.1% | -88,9 k € | +11.1% | -100,0 k € | +15.9% | -118,9 k € | |
| EBITDA | -644,6 k € | -24.5% | -517,7 k € | -39.6% | -370,9 k € | -20.0% | -309,1 k € | +23.7% | -405,2 k € | |
| Operating profit | -689,2 k € | -23.3% | -559,1 k € | -37.5% | -406,6 k € | -24.9% | -325,5 k € | +21.1% | -412,5 k € | |
| Profit/loss | -688,8 k € | -23.3% | -558,7 k € | -36.8% | -408,5 k € | -25.3% | -326,1 k € | +21.4% | -414,8 k € | |
| Equity | -2,4 M € | -40.3% | -1,7 M € | -48.6% | -1,1 M € | -55.2% | -740,3 k € | -78.7% | -414,3 k € | |
| Total assets | 292,4 k € | -19.1% | 361,3 k € | +5.0% | 344,2 k € | +9.7% | 313,8 k € | +276.9% | 83,3 k € | |
| Cash | 35,2 k € | -57.3% | 82,5 k € | +68.8% | 48,9 k € | +183.9% | 17,2 k € | +98.4% | 8,7 k € | |
| Debts | 2,7 M € | +29.8% | 2,1 M € | +38.6% | 1,5 M € | +41.7% | 1,1 M € | +112.8% | 493,8 k € | |
| Staff | 5,9 | 4,1 | 3,5 | 3 | 3 | |||||
Private limited company · Leuven · incorporated on 14/05/2019 · 5,9 ETP
Private limited company loss-making in the latest fiscal year. Cash position declining (-57.3%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Pledge Therapeutics is a Private limited company incorporated in 2019. Its main activity is: Manufacture of basic pharmaceutical products. Its registered office is in Leuven. It employs on average 5,9 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.